LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 815

Search options

  1. Article ; Online: Change in nomenclature for the immunologic synapse from Troxis Necrosis to trogocytosis.

    French, Samuel W

    Experimental and molecular pathology

    2017  Volume 103, Issue 2, Page(s) 162

    Abstract: ... Wang MX et al. and French SW. Exp Mol Pathol 2001, 71: 137-146). This mechanism of liver injury was ...

    Abstract The immunologic synapse mechanism of liver necrosis was termed Troxis Necrosis meaning "nibbling". (Wang MX et al. and French SW. Exp Mol Pathol 2001, 71: 137-146). This mechanism of liver injury was first named "Piecemeal Necrosis" by Hans Popper. It is involved in autoimmune hepatitis, HCV, HBV, primary biliary cirrhosis and steatohepatitis. This process involves the T cell receptor (TCR) which binds to the hepatocyte antigen presenting major histocompatibility complex (MHC) on the hepatocytic plasma membrane which quickly leads to the removal of the complex from the liver and uptake by the CD4 lymphocyte. This process is performed by the immunologic synapse now called trogocytosis meaning "gnaw" (Martinez-Martin N et al., Immunity 2011, 35: 208-222 and Dustin ML, Cancer Immunol Res 2014, 2: 1023-1033). The repeated episodes of uptake of the hepatocyte bite by bite causes the hepatocyte to slowly disappear like the Cheshire cat. This immunological synapse process is also involved in drug hepatitis, Hashimoto's thyroiditis, type I diabetes, autoimmune adrenalitis, autoimmune gastritis and cancer therapy. Treatment of Alzheimer's disease is also now being studied with PD-L1 antibody as used in the treatment of cancer allowing recruitment of disease modifying leukocytes to the sites of brain pathology (Schwartz M. Science 2017, 357: 254-255). Acknowledgement: Supported by a Grant from NIAAAUO1-021898.
    Language English
    Publishing date 2017-10
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 207655-x
    ISSN 1096-0945 ; 0014-4800
    ISSN (online) 1096-0945
    ISSN 0014-4800
    DOI 10.1016/j.yexmp.2017.08.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Chronic alcohol binging injures the liver and other organs by reducing NAD⁺ levels required for sirtuin's deacetylase activity.

    French, Samuel W

    Experimental and molecular pathology

    2016  Volume 100, Issue 2, Page(s) 303–306

    Abstract: NAD(+) levels are markedly reduced when blood alcohol levels are high during binge drinking. This causes liver injury to occur because the enzymes that require NAD(+) as a cofactor such as the sirtuin de-acetylases cannot de-acetylate acetylated proteins ...

    Abstract NAD(+) levels are markedly reduced when blood alcohol levels are high during binge drinking. This causes liver injury to occur because the enzymes that require NAD(+) as a cofactor such as the sirtuin de-acetylases cannot de-acetylate acetylated proteins such as acetylated histones. This prevents the epigenetic changes that regulate metabolic processes and which prevent organ injury such as fatty liver in response to alcohol abuse. Hyper acetylation of numerous regulatory proteins develops. Systemic multi-organ injury occurs when NAD(+) is reduced. For instance the Circadian clock is altered if NAD(+) is not available. Cell cycle arrest occurs due to up regulation of cell cycle inhibitors leading to DNA damage, mutations, apoptosis and tumorigenesis. NAD(+) is linked to aging in the regulation of telomere stability. NAD(+) is required for mitochondrial renewal. Alcohol dehydrogenase is present in every visceral organ in the body so that there is a systemic reduction of NAD(+) levels in all of these organs during binge drinking.
    MeSH term(s) Acetylation ; Alcohol Dehydrogenase/metabolism ; Binge Drinking/metabolism ; Binge Drinking/physiopathology ; Cell Cycle Checkpoints/physiology ; Humans ; Liver/metabolism ; Mitochondria/metabolism ; NAD/metabolism ; Signal Transduction/physiology ; Sirtuins/metabolism
    Chemical Substances NAD (0U46U6E8UK) ; Alcohol Dehydrogenase (EC 1.1.1.1) ; Sirtuins (EC 3.5.1.-)
    Language English
    Publishing date 2016-04
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 207655-x
    ISSN 1096-0945 ; 0014-4800
    ISSN (online) 1096-0945
    ISSN 0014-4800
    DOI 10.1016/j.yexmp.2016.02.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: How to prevent alcoholic liver disease.

    French, S W

    Experimental and molecular pathology

    2015  Volume 98, Issue 2, Page(s) 304–307

    Abstract: Betaine supplements of alcoholic beverages are proposed to prevent the development of alcoholic liver disease in patients that abuse alcohol. This recommendation is based on the observation of studies where it has been shown in binge drinking and chronic ...

    Abstract Betaine supplements of alcoholic beverages are proposed to prevent the development of alcoholic liver disease in patients that abuse alcohol. This recommendation is based on the observation of studies where it has been shown in binge drinking and chronic ethanol feeding animal models that betaine prevents liver injury resulting from high blood alcohol levels. The basic observation is that betaine added to ethanol being ingested increases the elimination rate of blood alcohol, which prevents the blood alcohol levels (BALs) from reaching high levels. The mechanism of how betaine does this is postulated to be that betaine causes the increase in the elimination rate by increasing the metabolic rate which generates NAD the rate limiting cofactor of alcohol oxidation by ADH. Betaine does this most likely by supporting the methylation of norepinephrine to form epinephrine by phenylethanolamine N-methyltransferase. Epinephrine is 5 to 10-fold more active than norepinephrine in increasing the metabolic rate.
    MeSH term(s) Alcoholism ; Animals ; Betaine/administration & dosage ; Betaine/therapeutic use ; Energy Metabolism/drug effects ; Epinephrine/biosynthesis ; Ethanol/blood ; Ethanol/metabolism ; Humans ; Liver/metabolism ; Liver Diseases, Alcoholic/metabolism ; Liver Diseases, Alcoholic/prevention & control ; Methylation/drug effects ; Models, Animal ; Norepinephrine/metabolism ; Oxidation-Reduction ; Phenylethanolamine N-Methyltransferase/metabolism ; Rats
    Chemical Substances Ethanol (3K9958V90M) ; Betaine (3SCV180C9W) ; Phenylethanolamine N-Methyltransferase (EC 2.1.1.28) ; Norepinephrine (X4W3ENH1CV) ; Epinephrine (YKH834O4BH)
    Language English
    Publishing date 2015-03-07
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 207655-x
    ISSN 1096-0945 ; 0014-4800
    ISSN (online) 1096-0945
    ISSN 0014-4800
    DOI 10.1016/j.yexmp.2015.03.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Successful treatment of severe immune checkpoint inhibitor associated autoimmune hepatitis with basiliximab: a case report.

    Zarrabi, Maiah / Hamilton, Camille / French, Samuel W / Federman, Noah / Nowicki, Theodore S

    Frontiers in immunology

    2023  Volume 14, Page(s) 1156746

    Abstract: Immune checkpoint inhibitors (ICIs) targeting programmed cell death-1 (PD-1) and its corresponding ligand PD-L1 are being increasingly used for a wide variety of cancers, including refractory sarcomas. Autoimmune hepatitis is a known side effect of ICIs, ...

    Abstract Immune checkpoint inhibitors (ICIs) targeting programmed cell death-1 (PD-1) and its corresponding ligand PD-L1 are being increasingly used for a wide variety of cancers, including refractory sarcomas. Autoimmune hepatitis is a known side effect of ICIs, and is typically managed with broad, non-specific immunosuppression. Here, we report a case of severe autoimmune hepatitis occurring after anti-PD-1 therapy with nivolumab in a patient with osteosarcoma. Following prolonged unsuccessful treatment with intravenous immunoglobulin, steroids, everolimus, tacrolimus, mycophenolate, and anti-thymoglobulin, the patient was eventually treated with the anti-CD25 monoclonal antibody basiliximab. This resulted in prompt, sustained resolution of her hepatitis without significant side effects. Our case demonstrates that basiliximab may be an effective therapy for steroid-refractory severe ICI-associated hepatitis.
    MeSH term(s) Humans ; Female ; Immune Checkpoint Inhibitors/adverse effects ; Basiliximab ; Hepatitis, Autoimmune/diagnosis ; Hepatitis, Autoimmune/drug therapy ; Hepatitis, Autoimmune/etiology ; Nivolumab/adverse effects ; Antibodies, Monoclonal/adverse effects
    Chemical Substances Immune Checkpoint Inhibitors ; Basiliximab (9927MT646M) ; Nivolumab (31YO63LBSN) ; Antibodies, Monoclonal
    Language English
    Publishing date 2023-05-30
    Publishing country Switzerland
    Document type Case Reports ; Research Support, N.I.H., Extramural ; Journal Article
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2023.1156746
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Current state of the epilepsy drug and device pipeline.

    Terman, Samuel W / Kirkpatrick, Laura / Akiyama, Lisa F / Baajour, Wadih / Atilgan, Deniz / Dorotan, Maria Kristina C / Choi, Hyoung Won / French, Jacqueline A

    Epilepsia

    2024  Volume 65, Issue 4, Page(s) 833–845

    Abstract: The field of epilepsy has undergone substantial advances as we develop novel drugs and devices. Yet considerable challenges remain in developing broadly effective, well-tolerated treatments, but also precision treatments for rare epilepsies and seizure- ... ...

    Abstract The field of epilepsy has undergone substantial advances as we develop novel drugs and devices. Yet considerable challenges remain in developing broadly effective, well-tolerated treatments, but also precision treatments for rare epilepsies and seizure-monitoring devices. We summarize major recent and ongoing innovations in diagnostic and therapeutic products presented at the seventeenth Epilepsy Therapies & Diagnostics Development (ETDD) conference, which occurred May 31 to June 2, 2023, in Aventura, Florida. Therapeutics under development are targeting genetics, ion channels and other neurotransmitters, and many other potentially first-in-class interventions such as stem cells, glycogen metabolism, cholesterol, the gut microbiome, and novel modalities for delivering electrical neuromodulation.
    MeSH term(s) Humans ; Anticonvulsants/therapeutic use ; Epilepsy/drug therapy ; Epilepsy/diagnosis ; Seizures/drug therapy
    Chemical Substances Anticonvulsants
    Language English
    Publishing date 2024-02-12
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 216382-2
    ISSN 1528-1167 ; 0013-9580
    ISSN (online) 1528-1167
    ISSN 0013-9580
    DOI 10.1111/epi.17884
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: An unexpected diagnosis of histiocytic sarcoma.

    Byers, Joshua T / French, Samuel W

    Experimental and molecular pathology

    2018  Volume 106, Page(s) 60–62

    MeSH term(s) Ascites/etiology ; Biomarkers, Tumor ; Diagnostic Errors ; Fatal Outcome ; Gastrointestinal Hemorrhage/etiology ; Hepatitis C, Chronic/complications ; Histiocytes/pathology ; Histiocytic Sarcoma/complications ; Histiocytic Sarcoma/diagnosis ; Histiocytic Sarcoma/metabolism ; Histiocytic Sarcoma/pathology ; Humans ; Male ; Middle Aged ; Peritoneal Neoplasms/chemistry ; Peritoneal Neoplasms/complications ; Peritoneal Neoplasms/diagnosis ; Peritoneal Neoplasms/pathology ; Peritonitis/diagnosis
    Chemical Substances Biomarkers, Tumor
    Language English
    Publishing date 2018-11-28
    Publishing country Netherlands
    Document type Case Reports ; Journal Article
    ZDB-ID 207655-x
    ISSN 1096-0945 ; 0014-4800
    ISSN (online) 1096-0945
    ISSN 0014-4800
    DOI 10.1016/j.yexmp.2018.11.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Piecemeal necrosis is due to the immunologic synapse formation and internalization of intact TCR-MHC II complexes by CD4 T cells.

    French, Samuel W / Lu, Jiajie G

    Experimental and molecular pathology

    2018  Volume 105, Issue 1, Page(s) 150–152

    Abstract: The nature of the immunologic synapse in autoimmune hepatitis is defined. This process involves the T cell receptor (TCR) which binds to the hepatocyte antigen presenting major histocompatibility complex (MHC) on the plasma membrane. This complex is ... ...

    Abstract The nature of the immunologic synapse in autoimmune hepatitis is defined. This process involves the T cell receptor (TCR) which binds to the hepatocyte antigen presenting major histocompatibility complex (MHC) on the plasma membrane. This complex is quickly removed from the liver cell and taken into the T cell cytoplasm to be digested by the lysosome. The liver cell is gradually diminished to the point of its total removal by the lymphocytes binding to it.
    MeSH term(s) CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/ultrastructure ; Hepatitis, Autoimmune/immunology ; Hepatitis, Autoimmune/pathology ; Histocompatibility Antigens Class II/immunology ; Humans ; Immunological Synapses/immunology ; Necrosis ; Receptors, Antigen, T-Cell/immunology
    Chemical Substances Histocompatibility Antigens Class II ; Receptors, Antigen, T-Cell
    Language English
    Publishing date 2018-07-17
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 207655-x
    ISSN 1096-0945 ; 0014-4800
    ISSN (online) 1096-0945
    ISSN 0014-4800
    DOI 10.1016/j.yexmp.2018.07.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: The Role of FAT10 in Alcoholic Hepatitis Pathogenesis.

    Jia, Yue / Ji, Ping / French, Samuel W

    Biomedicines

    2020  Volume 8, Issue 7

    Abstract: FAT10 expression is highly up-regulated by pro-inflammatory cytokines IFNγ and TNFα in all cell types and tissues. Increased FAT10 expression may induce increasing mitotic non-disjunction and chromosome instability, leading to tumorigenesis. In this ... ...

    Abstract FAT10 expression is highly up-regulated by pro-inflammatory cytokines IFNγ and TNFα in all cell types and tissues. Increased FAT10 expression may induce increasing mitotic non-disjunction and chromosome instability, leading to tumorigenesis. In this review, we summarized others' and our work on FAT10 expression in liver biopsy samples from patients with alcoholic hepatitis (AH). FAT10 is essential to maintain the function of liver cell protein quality control and Mallory-Denk body (MDB) formation. FAT10 overexpression in AH leads to balloon degeneration and MDB aggregation formation, all of which is prevented in fat10-/- mice. FAT10 causes the proteins' accumulation, overexpression, and forming MDBs through modulating 26s proteasome's proteases. The pathway that increases FAT10 expression includes TNFα/IFNγ and the interferon sequence response element (ISRE), followed by NFκB and STAT3, which were all up-regulated in AH. FAT10 was only reported in human and mouse specimens but plays critical role for the development of alcoholic hepatitis. Flavanone derivatives of milk thistle inhibit TNFα/IFNγ, NFκB, and STAT3, then inhibit the expression of FAT10. NFκB is the key nodal hub of the IFNα/TNFα-response genes. Studies on Silibinin and other milk thistle derivatives to treat AH confirms that overexpressed FAT10 is the major key molecule in these networks.
    Language English
    Publishing date 2020-07-01
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2720867-9
    ISSN 2227-9059
    ISSN 2227-9059
    DOI 10.3390/biomedicines8070189
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Epigenetic events in liver cancer resulting from alcoholic liver disease.

    French, Samuel W

    Alcohol research : current reviews

    2013  Volume 35, Issue 1, Page(s) 57–67

    Abstract: Epigenetic mechanisms play an extensive role in the development of liver cancer (i.e., hepatocellular carcinoma [HCC]) associated with alcoholic liver disease (ALD) as well as in liver disease associated with other conditions. For example, epigenetic ... ...

    Abstract Epigenetic mechanisms play an extensive role in the development of liver cancer (i.e., hepatocellular carcinoma [HCC]) associated with alcoholic liver disease (ALD) as well as in liver disease associated with other conditions. For example, epigenetic mechanisms, such as changes in the methylation and/or acetylation pattern of certain DNA regions or of the histone proteins around which the DNA is wrapped, contribute to the reversion of normal liver cells into progenitor and stem cells that can develop into HCC. Chronic exposure to beverage alcohol (i.e., ethanol) can induce all of these epigenetic changes. Thus, ethanol metabolism results in the formation of compounds that can cause changes in DNA methylation and interfere with other components of the normal processes regulating DNA methylation. Alcohol exposure also can alter histone acetylation/deacetylation and methylation patterns through a variety of mechanisms and signaling pathways. Alcohol also acts indirectly on another molecule called toll-like receptor 4 (TLR4) that is a key component in a crucial regulatory pathway in the cells and whose dysregulation is involved in the development of HCC. Finally, alcohol use regulates an epigenetic mechanism involving small molecules called miRNAs that control transcriptional events and the expression of genes important to ALD.
    MeSH term(s) Carcinoma, Hepatocellular/etiology ; Carcinoma, Hepatocellular/genetics ; Central Nervous System Depressants/adverse effects ; Epigenesis, Genetic ; Ethanol/adverse effects ; Liver Diseases, Alcoholic/complications ; Liver Diseases, Alcoholic/genetics ; Liver Neoplasms/etiology ; Liver Neoplasms/genetics
    Chemical Substances Central Nervous System Depressants ; Ethanol (3K9958V90M)
    Language English
    Publishing date 2013-11-07
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2168-3492
    ISSN 2168-3492
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: The importance of CYP2E1 in the pathogenesis of alcoholic liver disease and drug toxicity and the role of the proteasome.

    French, Samuel W

    Sub-cellular biochemistry

    2013  Volume 67, Page(s) 145–164

    Abstract: The chapter discusses about the critical role of CYP2E1 in ethanol mediated liver injury and its association with NASH. Ethanol metabolism by CYP2E1 generates hydroxyethyl radicals which promote ethanol hepatotoxicity. Greater induction of CYP2E1 and ... ...

    Abstract The chapter discusses about the critical role of CYP2E1 in ethanol mediated liver injury and its association with NASH. Ethanol metabolism by CYP2E1 generates hydroxyethyl radicals which promote ethanol hepatotoxicity. Greater induction of CYP2E1 and hence greater liver injury occurs with co-administration of ethanol and drugs. Induction of CYP2E1 leads to prominent epigenetic effects and CYP2E1 polymorphism may be associated with alcoholic liver disease. These are some aspects of CYP2E1, amongst many others which account for its importance in the context of drug metabolism and disease development and have been reviewed in the chapter.
    MeSH term(s) Animals ; Central Nervous System Depressants/toxicity ; Cytochrome P-450 CYP2E1/metabolism ; Drug-Related Side Effects and Adverse Reactions ; Ethanol/toxicity ; Humans ; Liver Diseases, Alcoholic/enzymology ; Liver Diseases, Alcoholic/etiology ; Proteasome Endopeptidase Complex/metabolism
    Chemical Substances Central Nervous System Depressants ; Ethanol (3K9958V90M) ; Cytochrome P-450 CYP2E1 (EC 1.14.13.-) ; Proteasome Endopeptidase Complex (EC 3.4.25.1)
    Language English
    Publishing date 2013
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 0306-0225 ; 0096-8757
    ISSN 0306-0225 ; 0096-8757
    DOI 10.1007/978-94-007-5881-0_4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top